Table 2 Impacts of diverse delayed extents on lesion characteristics and primary treatment strategies
From: Risk factors and negative consequences of patient’s delay for penile carcinoma
Variables | Lesion size, cm (≤2 vs. >2a) | Primary tumor (Tisb/Ta/T1a vs. T1b–T4) | Lymph nodes (N0 vs. N1–N3) | Distant metastasis (M0 vs. M1) | Primary strategies (penis-sparingc vs. othersd) | |||||
|---|---|---|---|---|---|---|---|---|---|---|
OR (95 % CI) | p value | OR (95 % CI) | p value | OR (95 % CI) | p value | OR (95 % CI) | p value | OR (95 % CI) | p value | |
Undelayed (n = 69) | Reference | Reference | Reference | Reference | Reference | |||||
Delay 1–3 months (n = 69) | 1.432 (0.679–3.018) | 0.342 | 1.502 (0.616–3.660) | 0.369 | 1.920 (0.609–6.055) | 0.259 | 1.015 (0.986–1.044) | 1.000e | 1.446 (0.543–3.850) | 0.459 |
Delay 3–6 months (n = 54) | 3.294 (1.533–7.077) | 0.002 | 2.950 (1.227–7.092) | 0.013 | 6.400 (2.192–18.689) | <0.001 | 1.059 (0.992–1.130) | 0.082e | 3.530 (1.376–8.891) | 0.007 |
Delay >6 months (n = 62) | 6.424 (2.993–13.787) | <0.001 | 3.726 (1.604–8.656) | 0.002 | 7.549 (2.653–21.483) | <0.001 | 1.107 (1.021–1.201) | 0.010e | 4.497 (1.830–11.052) | 0.001 |